Perm scientists presented their project of producing innovational complex prouct "Diphage", based on Acinetobacter baumannii and Pseudomonas aeruginosa

Opinion leaders of «Relatox®» presented the results of using Russian A-type botulinum toxin at the latest regional practice conference in Moscow.

The Ministry of Health and the Federal Service on Surveillance for consumer rights protection and human well-being (Rospotrebnadzor) announced that more than 5.5 million people in 82 regions were vaccinated

The Ufa branch of NGO Microgen developed a unique technology of effective post-treatment of an aqueous solution of the active substance of a symptom-modifying drug product Chondrolon-Pro

To determine the level of the main component (tick-borne encephalitis virus antigen), which determines the effectiveness of the vaccine, Russian specialists have developed and implemented an original method for assaying the antigen in the sample using ELISA and specialized computer analysis. 

According to specialists of this company, one of the main benefits of the novel combination vaccines is the lack of a preservative containing organic compounds of mercury, thimerosal.